MLNOV.PA vs. NBIX
MLNOV.PA (Novatech Industries) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. MLNOV.PA operates in Electronic Components (Technology), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, MLNOV.PA returned 22.87%/yr vs 12.89%/yr for NBIX. At a correlation of -0.01, they often move in opposite directions.
Performance
MLNOV.PA vs. NBIX - Performance Comparison
Loading charts...
Different Trading Currencies
MLNOV.PA is traded in EUR, while NBIX is traded in USD. To make them comparable, the NBIX values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, MLNOV.PA achieves a -24.75% return, which is significantly lower than NBIX's 25.52% return. Over the past 10 years, MLNOV.PA has outperformed NBIX with an annualized return of 22.87%, while NBIX has yielded a comparatively lower 12.89% annualized return.
MLNOV.PA
- 1D
- 0.00%
- 1M
- -9.15%
- 6M
- -24.75%
- YTD
- -24.75%
- 1Y
- 1.36%
- 3Y*
- 7.48%
- 5Y*
- 19.56%
- 10Y*
- 22.87%
- ALL TIME*
- 1.18%
NBIX
- 1D
- 1.45%
- 1M
- 9.74%
- 6M
- 32.78%
- YTD
- 25.52%
- 1Y
- 33.42%
- 3Y*
- 19.51%
- 5Y*
- 12.85%
- 10Y*
- 12.89%
- ALL TIME*
- 17.50%
MLNOV.PA vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MLNOV.PA Novatech Industries | -24.75% | 88.57% | 28.83% | 63.00% | -18.03% | -8.96% | 11.67% | -4.76% | 58.69% | 9.37% |
NBIX Neurocrine Biosciences, Inc. | 25.52% | -8.43% | 10.44% | 7.01% | 48.93% | -4.50% | -18.18% | 53.93% | -3.64% | 75.85% |
Correlation
The correlation between MLNOV.PA and NBIX is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2007 | -0.01 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLNOV.PA vs. NBIX — Risk / Return Rank
MLNOV.PA
NBIX
MLNOV.PA vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novatech Industries (MLNOV.PA) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLNOV.PA | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.94 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.21 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.05 | 1.48 | -1.43 |
| Martin ratioReturn relative to average drawdown | 0.15 | 3.36 | -3.21 |
Loading charts...
Drawdowns
MLNOV.PA vs. NBIX - Drawdown Comparison
The maximum MLNOV.PA drawdown since its inception was -93.88%, which is greater than NBIX's maximum drawdown of -84.86%. Use the drawdown chart below to compare losses from any high point for MLNOV.PA and NBIX.
Loading charts...
Drawdown Indicators
| MLNOV.PA | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.88% | -84.86% | -9.02% |
Max Drawdown (1Y)Largest decline over 1 year | -25.76% | -22.65% | -3.11% |
Max Drawdown (3Y)Largest decline over 3 years | -43.75% | -45.83% | +2.08% |
Max Drawdown (5Y)Largest decline over 5 years | -49.59% | -45.83% | -3.76% |
Max Drawdown (10Y)Largest decline over 10 years | -80.49% | -45.83% | -34.66% |
Current DrawdownCurrent decline from peak | -24.75% | -4.05% | -20.70% |
Average DrawdownAverage peak-to-trough decline | -52.82% | -28.42% | -24.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.15% | 9.98% | -0.83% |
Volatility
MLNOV.PA vs. NBIX - Volatility Comparison
Novatech Industries (MLNOV.PA) has a higher volatility of 14.66% compared to Neurocrine Biosciences, Inc. (NBIX) at 7.07%. This indicates that MLNOV.PA's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLNOV.PA | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.66% | 7.07% | +7.59% |
Volatility (6M)Calculated over the trailing 6-month period | 35.87% | 23.15% | +12.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.57% | 31.75% | +48.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.37% | 33.40% | +61.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 139.59% | 39.59% | +100.00% |
Dividends
MLNOV.PA vs. NBIX - Dividend Comparison
Neither MLNOV.PA nor NBIX has paid dividends to shareholders.
Financials
MLNOV.PA vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Novatech Industries and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLNOV.PA and NBIX have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MLNOV.PA and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer